CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Revitive IXdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02429310
NCT02429310N/ACompleted
CompareCT.gov

Adjuvant Benefit of Neuromuscular Electrical Stimulation to Supervised Exercise in Patients With Intermittent Claudication

Imperial College London·interventional·Posted Apr 29, 2015·Updated Oct 8, 2020

In Brief

A clinical study evaluating Revitive IX for Intermittent Claudication and 2 related conditions. Completed, enrolled 42 participants across 1 site.

Detailed Summary

This study will assess the adjuvant benefit of a neuromuscular electrical stimulation device to standard treatment of supervised exercise in patients suffering from symptoms and effects of lower limb Intermittent Claudication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntermittent Claudication, Peripheral Vascular Disease, Lower Limb Arterial Disease
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 29, 2015
Enrollment StartDec 1, 2014
Primary CompletionOct 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.2 years ago

Interventions

Revitive IXdevice

This is a neuromuscular electrical stimulation device